Expressions of HSP70 and Galectin7 in cervical carcinoma tissues with different radiotherapy sensitivity

Zeng Liang,Zhu Hong,Deng Yaping
DOI: https://doi.org/10.3969/j.issn.1004-7379.2007.11.005
2007-01-01
Abstract:Objective:To investigate expression and clinical pathological significance of HSP70 and Galectin7 in cervical carcinoma tissues with different radiotherapy sensitivity.Methods:Early cervical carcinoma tissues from 10 untreated cervical carcinoma patients were collected and diagnosed as medium differential squamous carcinoma.The fresh tissues were preserved in-80℃ refrigerator.After radiotherapy,the tissues were classified into two groups:high sensitivity group(HS) and low sensitivity group(LS)according to response evaluation criteria in solid tumors(RECIST).Tissue protein was extracted and separated by two-dimensional gel electrophoresis(2-DE) and analyzed by matrix assisted laser desorption/ionization time-of-flight mass spectrometry.Two differentially expression proteins were assayed by western blot and immunohistochemistry method.Results: The 2-DE gels were clear and showed high expression of Galectin7 in HS group,and high expression of HSP70 in LS group.The higher expression of Galectin7 in HS group and the higher expression of HSP70 in LS group were confirmed by Western Blot.Immunohistochemistry results showed that HSP70 positivity rate(21.7%,13/60) in HS group was significantly higher than that(85.7%,30/35)) in LS group(χ2= 36.5997,P<0.0001);Galectin7 positivity rate(91.7%,55/60) in HS group was significantly higher than that(40%,14/35) in LS group(χ2=29.6853,P<0.0001).Galectin7 expression was significantly stronger in HS group than that in LS group and HSP70 expression was significantly stronger in LS group than that in HS group.Conclusion: HSP70 and Galectin7 expression are assocaited with radiotherapy sensitivity.
What problem does this paper attempt to address?